Danone plans to acquire U.S. plant-based organic formula maker Kate Farms
HighlightsDanone, the French food giant, has agreed to acquire a majority stake in Kate Farms, a U.S. producer of plant-based organic drinks that caters to specialized nutrition needs. Kate Farms, founded in 2012 by Richard and Michelle Laver, offers formulas and shakes designed for individuals with health conditions, including those requiring tube feeding. The deal, which is subject to regulatory approval, will see Kate Farms' CEO, Brett Matthews, taking on the role of chairman and CEO of Danone's North American Medical Nutrition business.
Danone
said on Monday it has agreed to buy a majority stake in
Kate Farms
, a U.S. maker of plant-based organic drinks that will fit into the French food giant's
specialized nutrition
portfolio.
Santa Barbara, California-based Kate Farms makes formulas and shakes for everyday needs as well as for tube feeding for people with health conditions.
Richard and Michelle Laver founded the company in 2012 after their daughter Kate, who has cerebral palsy, had difficulties with eating. Their products are sold to hospitals and consumers across the country.
"We consider Kate Farms very complementary to our specialized nutrition offerings and capabilities, which we believe will allow us to reach more consumers and patients and bring a high-quality new standard of care to more people with a wider variety of health needs," Danone Group Deputy CEO Shane Grant said in an interview. "It's a really important build for us in the U.S."
The size of the majority stake and financial terms were not disclosed.
Paris-based Danone, which owns yogurt brand Activia, plant-based milk brand Silk and Evian water, signaled its interest in acquisitions after it reported strong 2024 earnings in February.
Kate Farms has previously raised money from investors such as Goldman Sachs Asset Management and Main Street Advisors. In 2022, it raised $75 million in a Series C growth capital round.
Kate Farms' senior management will retain a minority stake in the business, and its CEO, Brett Matthews, will serve as chairman and CEO of Danone's North American Medical Nutrition business.
Danone has been operating in the U.S. since 1942, and now has more than 5,000 U.S. employees and 13 U.S. manufacturing facilities and one research and development hub. It has a market value of about $57 billion. The deal is subject to regulatory approval.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
39 minutes ago
- New Indian Express
Pharma dept refuses to name 30 docs penalised for Paris, Monaco trip
NEW DELHI: Despite a Centre-appointed panel under the Department of Pharmaceuticals (DoP) reprimanding AbbVie Healthcare India Pvt Ltd for violating the uniform code for pharmaceutical marketing practice (UCPMP) by sponsoring trips to Monaco and Paris, in France, for 30 doctors worth Rs 1.91 crore, the department has refused to share the names of the 'offending' doctors against whom action was to be initiated. Revealing the names would involve disclosing personal information of individuals and it was not in public interest, the department said, defending its decision. Notably, the refusal to share the names of the doctors by the DoP under the Ministry of Chemicals and Fertilisers comes five months after activist Dr K V Babu filed an RTI over the matter. Moreover, the DoP is yet to share the names of the doctors with the National Medical Commission (NMC), which was asked by the Apex Committee for Pharma Marketing Practices to take action against the '30 offending healthcare professionals as per Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002' in its order on December 23, 2024. As per the norms, the doctor's licenses can be suspended if found guilty of violating the code of ethics. In its order, the committee also directed the Central Board of Direct Taxes to evaluate the tax liability of AbbVie Healthcare India Pvt Ltd, a subsidiary of US-based pharmaceutical company AbbVie Inc, for unethical marketing practices, along with the 30 doctors, and to take action in accordance with the provisions of the Income Tax Act, 1961.
Hindustan Times
an hour ago
- Hindustan Times
Planning to buy a ₹2 crore home? A large down payment can ease your EMI burden and reduce financial stress
We often come across headlines highlighting the booming demand in the luxury real estate segment, with properties worth crores flying off the shelves. While many of these homes are being snapped up by business owners and startup founders, it raises a broader question: Who else is buying such expensive properties? And if you're drawing a healthy salary, how expensive a home can you realistically afford? Probably not a ₹10 crore apartment, but what about something more modest, like a flat worth ₹2 crore? Take, for instance, Bengaluru-based IT professionals Raktim Mitra and Rupsa Mitra, both in their 40s. The couple recently purchased a home worth nearly ₹2 crore. With a combined annual income of ₹75 lakh, they fall in the upper-income bracket, yet their purchase was carefully calculated. Let's break it down. Assuming you want to purchase an apartment worth ₹2 crore through a loan. For a house of ₹2 crore, with a loan and down payment ratio of 80:20 and a loan tenure of 20 years, EMI would be around ₹1.4 lakh a month. and the loan amount will be ₹1.6 crore. This is when the lender charges 8.5% on the loan. Based on the widely accepted rule that EMIs should not exceed 40–45% of your monthly income, you'd need to earn at least ₹3–3.5 lakh per month (or ₹36–42 lakh annually) to comfortably service such a loan, provided you have minimal other liabilities. So, while a ₹2 crore home may seem like a stretch, it is within reach for dual-income families in high-paying sectors like tech, especially when prudent planning and financial discipline are in place. 'As recommended, the maximum EMI-to-income ratio is 40% of monthly net income. This means ₹3,46,798 or say ₹3.5 lakh monthly or a CTC of around ₹42 lakh. To make room for other and incidental expenses, the annual salary must be around ₹45-50 lakh (approximately),' says Madhupam Krishna, Securities and Exchange Board of India (Sebi)-registered investment advisor (RIA) and chief planner, WealthWisher Financial Planner and Advisors. Now, coming back to the down payment of ₹40 lakh plus 10% of fees, the actual required upfront is ₹50–55 lakh. So, if you are on similar financial levels and save 25% of your annual salary, you need seven to eight years of savings. This means that you can buy an expensive home if your salary is high enough. Or you can buy a home, if you pay a sizable down payment to bring your EMI down. In the above case, if you made a down payment of ₹1 crore, your EMI would be within ₹1 lakh, and you would have qualified for it even with a lower salary. 'Most lenders offer up to 80% of the property value as a loan. However, having a sizable upfront corpus helps. A larger down payment not only reduces the EMI burden but also improves your loan eligibility and approval chances,' says Sunil Dewali, co- CEO of Andromeda Sales and Distribution, parent company of Andromeda Realty Advisors. When assessing a home loan application, lenders typically evaluate three key factors: your credit score, your repayment capacity, and the quality of the property being mortgaged. Your credit score, issued by agencies like CIBIL, Experian, or Equifax, reflects how you've managed debt in the past. It takes into account your repayment history, any loan defaults, outstanding credit card dues, and overall credit behaviour. The score is typically 700+. If you have 750+, you may expect better terms. Income stability is key to home loan approval. For salaried individuals, bank checks, salary slips, Form 16, and bank statements for the last six to 12 months. For self-employed individuals, banks verify ITR, business turnover, balance sheets, and bank statements for two to three years. Banks also look at employer reputation, job stability, and industry,' says Krishna. Banks also assess your current debt-to-income ratio. If you already have EMIs (car loan, personal loan), it may reduce your home loan eligibility. Banks also carry out technical and legal due diligence on the property before approving a home loan. This process includes assessing the market value of the property, ensuring the title is clear, with no legal disputes, checking the track record of the developer and verifying RERA registration for under-construction projects. The process also includes verifying approved building plans and, in the case of ready-to-move-in properties, the occupancy or completion certificate. Also Read: Can you afford that 3,000 sq ft apartment after retirement? Think before you invest These checks help ensure that the property is legally sound and worth the investment being financed. For a larger loan amount, the bank may ask for a guarantor or a co-applicant. If your home loan EMI exceeds 40–45% of your take-home pay, you're entering the 'stress zone', and this may affect your ability to save and spend on other essentials. One must use the 50-30-20 rule. Allocate 50% of income for needs such as EMIs, premiums, essentials, 30% for lifestyle expenses, travel and rest 20% savings for life goals. 'When you take out a large loan, it can disrupt this ratio,' says Krishna. 'The key is to ensure that your EMI doesn't exceed 40% of your monthly income. While you might manage for the first year or two by adjusting expenses, it's not sustainable in the long run. That's why it's important to pause and assess before committing to a high-value loan.' Anagh Pal is a personal finance expert who writes on real estate, tax, insurance, mutual funds and other topics
Time of India
an hour ago
- Time of India
Fidelity marks up IPO-bound Lenskart's valuation to $6.1 billion
A fund managed by US-based Fidelity has marked up the valuation of omnichannel eyewear retailer Lenskart by over a fifth to $6.1 billion at the end of April 30, according to a monthly portfolio holdings update by the financial services major. This marks a 21% increase of the company's fair value in Fidelity's books compared to the $5 billion valuation at which it acquired the shares in June 2024 during a secondary transaction that also saw Singapore's Temasek join Lenskart's roster of blue-chip investors. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Play War Thunder now for free War Thunder Play Now Undo Crossover funds such as Fidelity, which invest both in publicly traded and privately held companies, periodically review the valuation of their portfolio companies. To be sure, the fair value of a company is ascertained on the basis of a number of factors, including financials shared with investors, market conditions and the performance of comparable peers. Since inception in 2010, Lenskart has closed nearly $2 billion in funding, including secondary deals. It is due to set up its largest eyewear manufacturing facility in Telangana with an investment of about Rs 1,500 crore. Live Events As reported by ET, the eyewear retailer is considering a $1 billion public offering at a potential $10 billion valuation, double that of its last funding round as reported by ET. Earlier this month, Lenskart converted into a public company by changing its registered name from Lenskart Solutions Private Limited to Lenskart Solutions Limited through a special resolution passed by its shareholders. Lenskart had closed a $200 million secondary round last June at a $5 billion valuation, with investments from Singapore's sovereign fund Temasek and Fidelity. Separately, in July 2024, Lenskart founders Peyush Bansal , Neha Bansal, Amit Choudhary, and Sumeet Kapahi had invested almost $20 million in the company. Previously, in March 2023, Lenskart had raised $600 million from Abu Dhabi Investment Authority and ChrysCapital. Of this, $450 million was a secondary share sale, which allowed existing investors such as SoftBank and Chiratae Ventures to partially sell their stake in the company. This round had valued Lenskart at $4.5 billion. Lenskart bagged the top honour at The Economic Times Startup Awards 2024 . It was named the Startup of the Year by an elite jury for its success in building a fast-growing, large-scale omnichannel consumer retail venture while creating an entirely new category. In FY24, Lenskart's net loss shrank to Rs 10 crore from Rs 64 crore in FY23, which the company attributed to technology-driven operational efficiencies. Operating revenue rose 43% to Rs 5,428 crore, while earnings before interest, taxes, depreciation, and amortisation (Ebitda) more than doubled to Rs 856 crore. The Gurugram- based company produces about 25 million frames and 30–40 million lenses annually. It operates over 2,500 stores across India and Southeast Asia in addition to a strong online presence. The company has yet to file financial statements for fiscal year 2025 with the Registrar of Companies.
